Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrew Harrison

Podiatrist San Francisco, CA Doctor of Podiatric Medicine

NPI 1649236399 CMS profile 695230

2299 Post St, Ste 203, San Francisco, CA 94115

Open in the dashboard

General payments

$999

26 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Andrew Harrison of San Francisco, CA is reported in the CMS Open Payments database as having received $999 across 26 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 53rd percentile of Podiatrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $176 6
2024 General $22 1
2023 General $165 4
2022 General $276 6
2021 General $332 7
2020 General $15 1
2019 General $12 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrew Harrison
  • Podiatrist median
  • Middle half of Podiatrist
  • National median

In program year 2025, general payments to Andrew Harrison were reported at $176. Among 4,572 Podiatrist profiles paid that year, the median was $260 and the middle half received between $94 and $777.

Show as a table
Year Andrew Harrison Podiatrist median Middle half National median
2019 $12 $196 $72–$601 $163
2020 $15 $118 $38–$335 $114
2021 $332 $169 $57–$573 $132
2022 $276 $220 $74–$782 $149
2023 $165 $208 $71–$635 $160
2024 $22 $237 $87–$681 $164
2025 $176 $260 $94–$777 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Musculoskeletal Transplant Foundation Inc. $271 4 payments
  2. Organogenesis Inc. $223 4 payments
  3. Stryker Corporation $144 4 payments
  4. Ortho Dermatologics, a division of Bausch Health US, LLC $98 1 payment
  5. Smith+Nephew, Inc. $71 4 payments
  6. Orthofix Medical, Inc. $41 2 payments
  7. Amgen Inc. $32 1 payment
  8. DePuy Synthes Sales Inc. $25 1 payment
  9. Alfasigma USA, Inc. $22 1 payment
  10. Evolution Surgical, Inc $22 1 payment
  11. Other $50 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $999 26 payments
Products named General payments · program years 2019–2025
  1. Puraply Antimicrobial $125 1 payment
  2. JUBLIA $98 1 payment
  3. Puraply $98 3 payments
  4. DART-FIRE $71 2 payments
  5. Physio-Stim $41 2 payments
  6. AUGMENT INJECTABLE $39 1 payment
  7. MAXLOCK EXTREME $34 1 payment
  8. KRYSTEXXA $32 1 payment
  9. HAT-TRICK $32 1 payment
  10. HEALIX KNOTLESS PEEK $25 1 payment
  11. Other $126 8 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 24 billing codes

Paid by Medicare

$91,122

Of which drugs: $309

Medicare patients

140

Average age 80

Services billed

1,370

83 women, 57 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 37%
Diabetes 36%
Ischemic heart disease 33%
Atrial fibrillation 29%
Depression 25%
Alzheimer's or dementia 24%
Heart failure 20%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 18 55 $306

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

26 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record